2024
Growth Phase Matters: Boosting immunity via Lacticasebacillus-derived membrane vesicles and their interactions with TLR2 pathways
SANDANUSOVÁ, Miriam; Kristyna TURKOVA; Eva PECHÁČKOVÁ; Jan KOTOUCEK; Pavel ROUDNICKÝ et. al.Základní údaje
Originální název
Growth Phase Matters: Boosting immunity via Lacticasebacillus-derived membrane vesicles and their interactions with TLR2 pathways
Autoři
SANDANUSOVÁ, Miriam (703 Slovensko, domácí); Kristyna TURKOVA (203 Česká republika); Eva PECHÁČKOVÁ (203 Česká republika, domácí); Jan KOTOUCEK (203 Česká republika); Pavel ROUDNICKÝ (203 Česká republika, domácí); Martin ŠINDELÁŘ (203 Česká republika, domácí); Lukáš KUBALA (203 Česká republika, domácí) a Gabriela AMBROZOVA (203 Česká republika)
Vydání
Journal of Extracellular Biology, Wiley, 2024, 2768-2811
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Kód RIV
RIV/00216224:14310/24:00138454
Organizační jednotka
Přírodovědecká fakulta
UT WoS
001533318700001
EID Scopus
2-s2.0-85208419294
Klíčová slova anglicky
growth curve; immunomodulation; Lacticaseibacillus rhamnosus; lipoteichoic acid; membrane vesicles; nanocarriers; TLR2
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 28. 7. 2025 10:42, Mgr. Michal Petr
Anotace
V originále
Lipid bi-layered particles known as membrane vesicles (MVs), produced by Gram-positive bacteria are a communication tool throughout the entire bacterial growth. However, the MVs characteristics may vary across all stages of maternal culture growth, leading to inconsistencies in MVs research. This, in turn, hinders their employment as nanocarriers, vaccines and other medical applications. In this study, we aimed to comprehensively characterize MVs derived from Lacticaseibacillus rhamnosus CCM7091 isolated at different growth stages: early exponential (6 h, MV6), late exponential (12 h, MV12) and late stationary phase (48 h, MV48). We observed significant differences in protein content between MV6 and MV48 (data are available via ProteomeXchange with identifier PXD041580), likely contributing to their different immunomodulatory capacities. In vitro analysis demonstrated that MV48 uptake rate by epithelial Caco-2 cells is significantly higher and they stimulate an immune response in murine macrophages RAW 264.7 (elevated production of TNFα, IL-6, IL-10, NO). This correlated with increased expression of lipoteichoic acid (LTA) and enhanced TLR2 signalling in MV48, suggesting that LTA contributes to the immunomodulation. In conclusion, we showed that Lacticaseibacillus rhamnosus CCM7091-derived MVs from the late stationary phase boost the immune response the most effectively, which pre-destines them for therapeutical application as nanocarriers.
Návaznosti
EF18_046/0015974, projekt VaV |
| ||
LX22NPO5104, projekt VaV |
| ||
MUNI/C/0023/2020, interní kód MU |
| ||
90242, velká výzkumná infrastruktura |
|